ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is characterized by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), representing 10%-20% of all breast cancers (2, 3).